Skip to Content

Boceprevir Capsules

Last Updated: December 9, 2015
Status: Current

Products Affected - Description

Victrelis oral capsule, Merck
200 mg, 28 bottles 12 count (NDC 00085-0314-02)

Reason for the Shortage

  • Merck Sharp & Dohme has made a business decision to discontinue Victrelis capsules in the US by December 2015.
  • Merck Sharp & Dohme is the sole supplier of boceprevir capsules.

Available Products

There is insufficient supply for usual ordering.

Estimated Resupply Dates

Merck Sharp & Dohme Victrelis 200 mg capsules available with an expiration date of December 2015. The company is discontinuing the product by December 2015.

Related Shortages


December 9, June 25, January 20, 2015, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.